SPDR S&P Biotech (XBI) 225.50 $XBI
Array BioPharma CEO Sees Big Opportunities in the Future
at The Street - Tue Mar 31, 3:27PM CDT
Ron Squarer, CEO of Array BioPharma, says the company has several late-stage clinical trials underway, and their success could build momentum.
XBI: 225.50 (+1.13), AZN: 68.43 (-1.51), IBB: 343.43 (-7.89), NVS: 98.61 (-2.70), ARRY: 7.37 (-0.17)
Biotech ETFs in Focus after a Choppy Week - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Mar 31, 11:57AM CDT
Biotech ETFs are recovering from one of the worst sell-offs of this year.
PBE: 55.14 (-1.11), SBIO: 29.87 (-0.25), SPY: 206.43 (-1.82), FBT: 118.23 (-2.67), XBI: 225.50 (+1.13), BBH: 129.58 (-3.38), IBB: 343.43 (-7.89)
Bankrupt Introgen Seeks Reincarnation IPO in Biotech Bubble
at The Street - Tue Mar 31, 10:30AM CDT
Will the biotech bubble support the comeback of Introgen Therapeutics, one of the sector's largest disasters?
XBI: 225.50 (+1.13)
These 3 ETFs Are Crushing the Market in 2015
Dan Caplinger, The Motley Fool - Motley Fool - Tue Mar 31, 9:31AM CDT
As the first quarter comes to a close, stock market investors have seen a lot of volatility but not much progress. After wild swings in both directions, the S&P 500 came into the last day of the quarter with a gain of just over 1%, while the ...
HEDJ: 66.14 (-0.53), FSLR: 59.79 (-0.90), XBI: 225.50 (+1.13), TAN: 44.43 (-0.44), SPWR: 31.31 (-0.14)
Biotech Weekly: Top Value Biotech Picks Starting Q2 2015
Daniel Ward - at Seeking Alpha - Mon Mar 30, 8:43AM CDT
LOXO: 12.45 (-0.10), TENX: 3.26 (+0.12), QLTI: 3.91 (-0.02), ECYT: 6.26 (-0.03), TNXP: 6.32 (+0.05), BOTA: 2.30 (+0.04), XBI: 225.50 (+1.13), DARA: 0.73 (-0.03), IBB: 343.43 (-7.89), MEIP: 1.79 (+0.04)
Selloff In Biotech, Semiconductor ETFs: A Nice Entry Point?
Zacks Funds - Seeking Alpha - Sun Mar 29, 12:29PM CDT
The U.S. stock market suffered the steepest decline in the Wednesday trading session, as concerns over the lofty valuations in biotech and semiconductors unnerved investors. In addition, a surprise drop in durable goods, Middle East tensions, and...
SBIO: 29.87 (-0.25), BBC: 32.83 (-0.63), PSI: 27.00 (-0.32), XBI: 225.50 (+1.13), SMH: 55.30 (-0.56), SOXX: 94.02 (-1.07), XSD: 87.68 (-1.05)
Young Investors Should Hope for a Pullback Sooner Rather Than Later
at The Street - Fri Mar 27, 1:53PM CDT
The CNBC 'Fast Money Halftime' traders discuss attributes young investors should look to develop for the markets, while a market pro weighs in with his top picks.
AMZN: 372.10 (-2.49), ZIOP: 10.77 (-0.84), XBI: 225.50 (+1.13), IBB: 343.43 (-7.89), INXN: 28.20 (+0.14), TLT: 130.69 (+0.28), TBT: 41.87 (-0.20), LEN: 51.81 (+0.32), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), XHB: 36.86 (+0.01), P: 16.21 (-0.18), GILD: 98.13 (-2.56), KITE: 57.68 (-2.30), PHM: 22.23 (-0.21), DIA: 177.58 (-1.81), ITB: 28.23 (-0.03), JUNO: 60.66 (-0.09), IWM: 124.37 (-0.40), KBH: 15.62 (-0.04), AAPL: 124.43 (-1.94), ZU: 12.99 (-0.38), BABA: 83.24 (-0.66)
A Buyback Or Biotech Bubble?
Leo Kolivakis - Seeking Alpha - Fri Mar 27, 1:37PM CDT
(click to enlarge) Steven Davidoff Solomon, professor of law at the University of California, Berkeley, wrote a comment for the New York Times reports, General Motors' Stock Buyback Follows a Worrying Trend : General Motors' announcement that...
BIIB: 422.24 (-9.38), GILD: 98.13 (-2.56), XBI: 225.50 (+1.13), IBB: 343.43 (-7.89), PKW: 49.31 (-0.38), CELG: 115.28 (-4.74)
Today's Market: Biotech Correction, Social Media News And Geopolitical Events Moving Stocks
Matthew Smith - at Seeking Alpha - Thu Mar 26, 9:10AM CDT
YHOO: 44.44 (-0.51), BIIB: 422.24 (-9.38), GILD: 98.13 (-2.56), FB: 82.21 (-0.98), XBI: 225.50 (+1.13), IBB: 343.43 (-7.89), AMGN: 159.85 (-4.45), GOOGL: 554.70 (-6.44), TWTR: 50.08 (+0.19), GOOG: 548.00 (-4.03), CELG: 115.28 (-4.74)
Sell-Off in Biotech, Semiconductor ETFs: A Nice Entry Point? - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Mar 26, 9:00AM CDT
Given bullish fundamentals, the current beaten down prices for biotech and semiconductor ETFs could be viewed as a buying opportunity.
SBIO: 29.87 (-0.25), BBC: 32.83 (-0.63), PSI: 27.00 (-0.32), XBI: 225.50 (+1.13), SMH: 55.30 (-0.56), SOXX: 94.02 (-1.07), XSD: 87.68 (-1.05)
Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing
at The Street - Thu Mar 26, 6:17AM CDT
If history repeats itself, the recent weakness in biotech stocks will end with lots more buying.
PCYC: 255.95 (-0.48), XBI: 225.50 (+1.13), ITMN: 73.89 (-0.02), NPSP: 45.97 (+0.01), IBB: 343.43 (-7.89)
'Fast Money' Recap: The 3 Reasons Stocks Tanked Wednesday
at The Street - Thu Mar 26, 4:00AM CDT
The trading panel discussed the declines in biotech, transports and semiconductors.
FDX: 165.45 (-1.30), BIIB: 422.24 (-9.38), MU: 27.13 (+0.45), OIH: 33.71 (-0.19), XBI: 225.50 (+1.13), AMGN: 159.85 (-4.45), BNO: 20.50 (-0.43), IBB: 343.43 (-7.89), SMH: 55.30 (-0.56), INTC: 31.27 (-0.19), TLT: 130.69 (+0.28), CELG: 115.28 (-4.74), NVDA: 20.92 (-0.55), SAN: 7.45 (-0.05), SAVE: 77.36 (-0.94), GILD: 98.13 (-2.56), QCOM: 69.34 (+0.46), IYT: 156.62 (-0.84)
Selloff in Biotech Continues; Should You Worry About Tech Sector?
at The Street - Wed Mar 25, 1:28PM CDT
The CNBC ‘Fast Money Halftime’ trading panel looks at biotech stocks, the broader market and the tech sector.
BIIB: 422.24 (-9.38), TROW: 80.98 (-0.76), BLK: 365.84 (-2.26), XBI: 225.50 (+1.13), AMGN: 159.85 (-4.45), FNF: 36.76 (+0.17), IBB: 343.43 (-7.89), TLT: 130.69 (+0.28), TBT: 41.87 (-0.20), CELG: 115.28 (-4.74), VLO: 63.62 (-0.14), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), GILD: 98.13 (-2.56), DIA: 177.58 (-1.81), XLK: 41.44 (-0.43), IWM: 124.37 (-0.40), XLF: 24.11 (-0.17), AAPL: 124.43 (-1.94), REGN: 451.48 (-8.30)
XBI Is +24.22% YTD And +44.70% For 2014, But What Are The Risks?
Reuben Sushman - at Seeking Alpha - Tue Mar 24, 5:53PM CDT
XBI: 225.50 (+1.13), IBB: 343.43 (-7.89), BBH: 129.58 (-3.38)
Look for Shares of SPDR S&P Biotech ETF to Potentially Rebound after Yesterday's 2.00% Sell Off
Comtex SmarTrend(R) - Mon Mar 23, 4:29PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $226.70 to a high of $232.97. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $228.78 on volume of 971,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 225.50 (+1.13)
3 Biotech Stocks to Buy If the Sector Crashes
Brian Orelli, Dan Caplinger, and Todd Campbell, The Motley Fool - Motley Fool - Mon Mar 23, 12:56PM CDT
The biotech sector has been on a roll lately. The SPDR S&P Biotech ETF has more than tripled since the start of 2012, compared to "just" a 63% increase in the S&P 500 . Source: Jeff Kubina via Flickr . Are we in a bubble that's...
BIIB: 422.24 (-9.38), ALNY: 104.42 (-3.36), XBI: 225.50 (+1.13), IBB: 343.43 (-7.89), SNY: 49.44 (-0.80), CELG: 115.28 (-4.74)
SPDR S&P Biotech announces quarterly distribution of $0.245
Seeking Alpha - at Seeking Alpha - Fri Mar 20, 1:18PM CDT
XBI: 225.50 (+1.13)
Uptrend Call Working As SPDR S&P Biotech ETF Stock Rises 51.9% (XBI)
Comtex SmarTrend(R) - Fri Mar 20, 9:49AM CDT
SmarTrend identified an Uptrend for SPDR S&P Biotech ETF (AMEX:XBI) on October 17th, 2014 at $158.01. In approximately 5 months, SPDR S&P Biotech ETF has returned 51.89% as of today's recent price of $239.99.
XBI: 225.50 (+1.13)
Array BioPharma CEO Sees Big Opportunities in the Future
at The Street - Tue Mar 31, 3:27PM CDT
Ron Squarer, CEO of Array BioPharma, says the company has several late-stage clinical trials underway, and their success could build momentum.
XBI: 225.50 (+1.13), AZN: 68.43 (-1.51), IBB: 343.43 (-7.89), NVS: 98.61 (-2.70), ARRY: 7.37 (-0.17)
Biotech ETFs in Focus after a Choppy Week - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Mar 31, 11:57AM CDT
Biotech ETFs are recovering from one of the worst sell-offs of this year.
PBE: 55.14 (-1.11), SBIO: 29.87 (-0.25), SPY: 206.43 (-1.82), FBT: 118.23 (-2.67), XBI: 225.50 (+1.13), BBH: 129.58 (-3.38), IBB: 343.43 (-7.89)
Bankrupt Introgen Seeks Reincarnation IPO in Biotech Bubble
at The Street - Tue Mar 31, 10:30AM CDT
Will the biotech bubble support the comeback of Introgen Therapeutics, one of the sector's largest disasters?
XBI: 225.50 (+1.13)
These 3 ETFs Are Crushing the Market in 2015
Dan Caplinger, The Motley Fool - Motley Fool - Tue Mar 31, 9:31AM CDT
As the first quarter comes to a close, stock market investors have seen a lot of volatility but not much progress. After wild swings in both directions, the S&P 500 came into the last day of the quarter with a gain of just over 1%, while the ...
HEDJ: 66.14 (-0.53), FSLR: 59.79 (-0.90), XBI: 225.50 (+1.13), TAN: 44.43 (-0.44), SPWR: 31.31 (-0.14)
Biotech Weekly: Top Value Biotech Picks Starting Q2 2015
Daniel Ward - at Seeking Alpha - Mon Mar 30, 8:43AM CDT
LOXO: 12.45 (-0.10), TENX: 3.26 (+0.12), QLTI: 3.91 (-0.02), ECYT: 6.26 (-0.03), TNXP: 6.32 (+0.05), BOTA: 2.30 (+0.04), XBI: 225.50 (+1.13), DARA: 0.73 (-0.03), IBB: 343.43 (-7.89), MEIP: 1.79 (+0.04)
Selloff In Biotech, Semiconductor ETFs: A Nice Entry Point?
Zacks Funds - Seeking Alpha - Sun Mar 29, 12:29PM CDT
The U.S. stock market suffered the steepest decline in the Wednesday trading session, as concerns over the lofty valuations in biotech and semiconductors unnerved investors. In addition, a surprise drop in durable goods, Middle East tensions, and...
SBIO: 29.87 (-0.25), BBC: 32.83 (-0.63), PSI: 27.00 (-0.32), XBI: 225.50 (+1.13), SMH: 55.30 (-0.56), SOXX: 94.02 (-1.07), XSD: 87.68 (-1.05)
Young Investors Should Hope for a Pullback Sooner Rather Than Later
at The Street - Fri Mar 27, 1:53PM CDT
The CNBC 'Fast Money Halftime' traders discuss attributes young investors should look to develop for the markets, while a market pro weighs in with his top picks.
AMZN: 372.10 (-2.49), ZIOP: 10.77 (-0.84), XBI: 225.50 (+1.13), IBB: 343.43 (-7.89), INXN: 28.20 (+0.14), TLT: 130.69 (+0.28), TBT: 41.87 (-0.20), LEN: 51.81 (+0.32), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), XHB: 36.86 (+0.01), P: 16.21 (-0.18), GILD: 98.13 (-2.56), KITE: 57.68 (-2.30), PHM: 22.23 (-0.21), DIA: 177.58 (-1.81), ITB: 28.23 (-0.03), JUNO: 60.66 (-0.09), IWM: 124.37 (-0.40), KBH: 15.62 (-0.04), AAPL: 124.43 (-1.94), ZU: 12.99 (-0.38), BABA: 83.24 (-0.66)
A Buyback Or Biotech Bubble?
Leo Kolivakis - Seeking Alpha - Fri Mar 27, 1:37PM CDT
(click to enlarge) Steven Davidoff Solomon, professor of law at the University of California, Berkeley, wrote a comment for the New York Times reports, General Motors' Stock Buyback Follows a Worrying Trend : General Motors' announcement that...
BIIB: 422.24 (-9.38), GILD: 98.13 (-2.56), XBI: 225.50 (+1.13), IBB: 343.43 (-7.89), PKW: 49.31 (-0.38), CELG: 115.28 (-4.74)
Today's Market: Biotech Correction, Social Media News And Geopolitical Events Moving Stocks
Matthew Smith - at Seeking Alpha - Thu Mar 26, 9:10AM CDT
YHOO: 44.44 (-0.51), BIIB: 422.24 (-9.38), GILD: 98.13 (-2.56), FB: 82.21 (-0.98), XBI: 225.50 (+1.13), IBB: 343.43 (-7.89), AMGN: 159.85 (-4.45), GOOGL: 554.70 (-6.44), TWTR: 50.08 (+0.19), GOOG: 548.00 (-4.03), CELG: 115.28 (-4.74)
Sell-Off in Biotech, Semiconductor ETFs: A Nice Entry Point? - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Mar 26, 9:00AM CDT
Given bullish fundamentals, the current beaten down prices for biotech and semiconductor ETFs could be viewed as a buying opportunity.
SBIO: 29.87 (-0.25), BBC: 32.83 (-0.63), PSI: 27.00 (-0.32), XBI: 225.50 (+1.13), SMH: 55.30 (-0.56), SOXX: 94.02 (-1.07), XSD: 87.68 (-1.05)
Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing
at The Street - Thu Mar 26, 6:17AM CDT
If history repeats itself, the recent weakness in biotech stocks will end with lots more buying.
PCYC: 255.95 (-0.48), XBI: 225.50 (+1.13), ITMN: 73.89 (-0.02), NPSP: 45.97 (+0.01), IBB: 343.43 (-7.89)
'Fast Money' Recap: The 3 Reasons Stocks Tanked Wednesday
at The Street - Thu Mar 26, 4:00AM CDT
The trading panel discussed the declines in biotech, transports and semiconductors.
FDX: 165.45 (-1.30), BIIB: 422.24 (-9.38), MU: 27.13 (+0.45), OIH: 33.71 (-0.19), XBI: 225.50 (+1.13), AMGN: 159.85 (-4.45), BNO: 20.50 (-0.43), IBB: 343.43 (-7.89), SMH: 55.30 (-0.56), INTC: 31.27 (-0.19), TLT: 130.69 (+0.28), CELG: 115.28 (-4.74), NVDA: 20.92 (-0.55), SAN: 7.45 (-0.05), SAVE: 77.36 (-0.94), GILD: 98.13 (-2.56), QCOM: 69.34 (+0.46), IYT: 156.62 (-0.84)
Selloff in Biotech Continues; Should You Worry About Tech Sector?
at The Street - Wed Mar 25, 1:28PM CDT
The CNBC ‘Fast Money Halftime’ trading panel looks at biotech stocks, the broader market and the tech sector.
BIIB: 422.24 (-9.38), TROW: 80.98 (-0.76), BLK: 365.84 (-2.26), XBI: 225.50 (+1.13), AMGN: 159.85 (-4.45), FNF: 36.76 (+0.17), IBB: 343.43 (-7.89), TLT: 130.69 (+0.28), TBT: 41.87 (-0.20), CELG: 115.28 (-4.74), VLO: 63.62 (-0.14), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), GILD: 98.13 (-2.56), DIA: 177.58 (-1.81), XLK: 41.44 (-0.43), IWM: 124.37 (-0.40), XLF: 24.11 (-0.17), AAPL: 124.43 (-1.94), REGN: 451.48 (-8.30)
XBI Is +24.22% YTD And +44.70% For 2014, But What Are The Risks?
Reuben Sushman - at Seeking Alpha - Tue Mar 24, 5:53PM CDT
XBI: 225.50 (+1.13), IBB: 343.43 (-7.89), BBH: 129.58 (-3.38)
Look for Shares of SPDR S&P Biotech ETF to Potentially Rebound after Yesterday's 2.00% Sell Off
Comtex SmarTrend(R) - Mon Mar 23, 4:29PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $226.70 to a high of $232.97. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $228.78 on volume of 971,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 225.50 (+1.13)
3 Biotech Stocks to Buy If the Sector Crashes
Brian Orelli, Dan Caplinger, and Todd Campbell, The Motley Fool - Motley Fool - Mon Mar 23, 12:56PM CDT
The biotech sector has been on a roll lately. The SPDR S&P Biotech ETF has more than tripled since the start of 2012, compared to "just" a 63% increase in the S&P 500 . Source: Jeff Kubina via Flickr . Are we in a bubble that's...
BIIB: 422.24 (-9.38), ALNY: 104.42 (-3.36), XBI: 225.50 (+1.13), IBB: 343.43 (-7.89), SNY: 49.44 (-0.80), CELG: 115.28 (-4.74)
SPDR S&P Biotech announces quarterly distribution of $0.245
Seeking Alpha - at Seeking Alpha - Fri Mar 20, 1:18PM CDT
XBI: 225.50 (+1.13)
Uptrend Call Working As SPDR S&P Biotech ETF Stock Rises 51.9% (XBI)
Comtex SmarTrend(R) - Fri Mar 20, 9:49AM CDT
SmarTrend identified an Uptrend for SPDR S&P Biotech ETF (AMEX:XBI) on October 17th, 2014 at $158.01. In approximately 5 months, SPDR S&P Biotech ETF has returned 51.89% as of today's recent price of $239.99.
XBI: 225.50 (+1.13)
